← Back to Clinical Trials
Recruiting NCT07338500

NCT07338500 Cardiovascular Effects of Music Versus Guided Mindfulness

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07338500
Status Recruiting
Phase
Sponsor Sir Mortimer B. Davis - Jewish General Hospital
Condition Music Listening Intervention
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2026-04-10
Primary Completion 2026-06

Trial Parameters

Condition Music Listening Intervention
Sponsor Sir Mortimer B. Davis - Jewish General Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 18 Years
Max Age 75 Years
Start Date 2026-04-10
Completion 2026-06
Interventions
MusicMindfulness

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this study is to examine how listening to music compares to guided mindfulness in affecting blood pressure, heart rate, and feelings of anxiety in healthy adults. The investigators aim to determine whether one of these approaches is more effective in reducing these variables. Additionally, the study will explore whether personal traits or preferences, measured using questionnaires, influence how participants respond to music or mindfulness. Based on previous clinical findings, the researchers hypothesize that listening to music will lead to greater reductions in blood pressure and heart rate compared to guided mindfulness.

Eligibility Criteria

Inclusion Criteria: * Normal baseline blood pressure (systolic BP \< 120 mmHg and diastolic BP \< 80mmHg). * Abstention from caffeine intake for at least 12 hours before the study session and throughout the session, as caffeine may influence cardiovascular measurements. * Abstention from using nicotine or tobacco products for at least 1 hour before the study session and throughout the session, as these substances may influence cardiovascular measurements. Exclusion Criteria: * Significant hearing impairments that cannot be improved with hearing aids or sound amplification. * Current use of medications that could affect blood pressure. * History of hypertension or cardiovascular disease. * Diagnosis of active substance use disorder, or reported patterns of alcohol, cannabis, or recreational/non-prescribed substance use likely to affect cardiovascular function.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology